Nathalie Carvalho Leite
Instituição:
Universidade Federal do Rio de Janeiro
Centro:
Hospital Universitário Clementino Fraga/CCS
Unidade:
Hospital Universitário Clementino Fraga/CCS
Departamento:
Divisão Médica DMD/HU
Formação:
-
Universidade Federal do Rio de Janeiro
clínica médica | Doutorado | 2007 - 2010
-
Universidade Federal do Rio de Janeiro
Medicina Interna | Mestrado | 1991 - 1995
-
Universidade Federal do Rio de Janeiro
| Especialização - Residência medica | 1989 - 1991
-
Universidade Federal do Rio de Janeiro
medicina | Graduação | 1983 - 1988
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:
(96.83% artigos com DOI)
| Titulo | DOI | Ano |
|---|---|---|
| Effects of Weight Loss and Interaction with Physical Activity on Risks of Cardiovascular Outcomes in Individuals with Type 2 Diabetes | 10.3803/enm.2023.1690 | 2023 |
| Relative prognostic importance of aortic and brachial blood pressures for cardiovascular and mortality outcomes in patients with resistant hypertension and diabetes: a two cohorts prospective study | 10.1097/hjh.0000000000003387 | 2023 |
| Effects of body weight variability on risks of macro- and microvascular outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort | 10.1016/j.diabres.2023.110992 | 2023 |
| Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease | 10.1007/s10620-023-08214-7 | 2023 |
| Prognostic Impact of On-Treatment Cumulative Ambulatory Blood Pressures for Adverse Macro- and Microvascular Outcomes in Individuals With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort | 10.1161/HYPERTENSIONAHA.123.21514 | 2023 |
| Prognostic importance of cardiovascular autonomic neuropathy on cardiovascular and mortality outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort | 10.1016/j.diabres.2022.110232 | 2023 |
| Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic | 10.20945/2359-4292-2023-0123 | 2023 |
| Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial | 10.1016/j.clnesp.2023.06.027 | 2023 |
| Relationship of ferritin and hepcidin with disease severity in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus | 10.1111/liv.15747 | 2023 |
| Prognostic impact of changes in aortic stiffness for cardiovascular and mortality outcomes in individuals with type 2 diabetes: the Rio de Janeiro cohort study | 10.1186/s12933-022-01514-8 | 2022 |
| Differential effects of treatment targets on risks of adverse outcomes according to diabetes duration, age and complications: Can these characteristics be used to individualize diabetes treatment? The Rio de Janeiro type 2 diabetes cohort | 10.1016/j.jdiacomp.2021.108124 | 2022 |
| Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring | 10.3748/wjg.v28.i25.2890 | 2022 |
| Validation and Performance of FibroScan®-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease | 10.1007/s10620-021-07363-x | 2022 |
| Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study | 10.1186/s12933-021-01324-4 | 2021 |
| Traditional and non-traditional risk factors for peripheral artery disease development/progression in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study | 10.1186/s12933-021-01249-y | 2021 |
| Importance of non-invasive liver fibrosis scores for mortality and complications development in individuals with type 2 diabetes | 10.1016/j.jdiacomp.2021.107879 | 2021 |
| Prognostic impact of short-term ambulatory blood pressure variability for microvascular and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study | 10.1097/hjh.0000000000002710 | 2021 |
| Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study | 10.1186/s12933-021-01388-2 | 2021 |
| Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study | 10.1186/s12933-020-01030-7 | 2020 |
| Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis | 10.1016/j.aohep.2019.05.011 | 2020 |
| Association between serum and dietary antioxidant micronutrients and advanced liver fibrosis in non-alcoholic fatty liver disease: an observational study | 10.7717/peerj.9838 | 2020 |
| Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? | 10.4254/wjh.v12.i9.661 | 2020 |
| Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial | 10.3390/nu12113372 | 2020 |
| Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease | 10.1016/j.aohep.2020.09.006 | 2020 |
| PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease? | 10.1016/j.numecd.2019.06.002 | 2019 |
| Efficacy of Diacerein in Reducing Liver Steatosis and Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: a Randomized, Placebo-Controlled Trial. | 10.1111/dom.13643 | 2019 |
| Prognostic Importance of Resistant Hypertension in Patients With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study | 10.2337/dc19-1534 | 2019 |
| Reply to Drs Mantovani and Zusi | 10.1016/j.numecd.2019.09.010 | 2019 |
| Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD) | 10.1016/j.aohep.2018.09.003 | 2019 |
| The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort | 10.1097/meg.0000000000001496 | 2019 |
| Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study | 10.1186/s12933-019-0809-1 | 2019 |
| Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study | 10.1186/s12933-018-0677-0 | 2018 |
| Prognostic impact of the ankle-brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study | 10.1007/s00125-018-4709-9 | 2018 |
| Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study | 10.1007/s00125-017-4484-z | 2018 |
| Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study | 10.1016/j.jdiacomp.2018.05.010 | 2018 |
| Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease | 10.3390/nu10111586 | 2018 |
| Treatment Adherence and Its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study | 10.1155/2018/8970196 | 2018 |
| Predictors of Development and Progression of Retinopathy in Patients with Type 2 Diabetes: Importance of Blood Pressure Parameters | 10.1038/s41598-017-05159-6 | 2017 |
| Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial | 10.2337/dc17-0374 | 2017 |
| Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio-T2DM cohort study | 10.1111/liv.12994 | 2016 |
| NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms? | 10.3390/ijms17040460 | 2016 |
| Prevalence of subclinical hypercortisolism in type 2 diabetic patients from the Rio de Janeiro Type 2 Diabetes Cohort Study | 10.1016/j.jdiacomp.2016.05.006 | 2016 |
| The Correlation Between Obesity-Related Diseases and Non-alcoholic Fatty Liver Disease in Women in the Pre-operative Evaluation for Bariatric Surgery Assessed by Transient Hepatic Elastography | 10.1007/s11695-016-2054-y | 2016 |
| Prognostic Importance of C¿Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study | 10.1161/jaha.116.004554 | 2016 |
| Correlates of Aortic Stiffness Progression in Patients With Type 2 Diabetes: Importance of Glycemic Control | 10.2337/dc14-2791 | 2015 |
| Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study | 10.1007/s00592-014-0592-0 | 2015 |
| Effects of Continuous Positive Airway Pressure Treatment on Clinic and Ambulatory Blood Pressures in Patients With Obstructive Sleep Apnea and Resistant Hypertension: A Randomized Controlled Trial | 10.1161/hypertensionaha.114.04852 | 2015 |
| Non-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment | 10.3748/wjg.v20.i26.8377 | 2014 |
| Relationships between reduced heart rate variability and pre-clinical cardiovascular disease in patients with type 2 diabetes | 10.1016/j.diabres.2014.07.005 | 2014 |
| Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis | 10.1111/j.1872-034X.2012.01106.x | 2013 |
| Prognostic Impact of Aortic Stiffness in High-Risk Type 2 Diabetic Patients: The Rio de Janeiro Type 2 Diabetes Cohort Study | 10.2337/dc13-0506 | 2013 |
| Factors associated with abnormal T-wave axis and increased QRS-T angle in type 2 diabetes | 10.1007/s00592-013-0483-9 | 2013 |
| Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients | 10.1097/hjh.0b013e328364103f | 2013 |
| Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients | 10.1097/hjh.0b013e328352aba6 | 2012 |
| Thresholds of Ambulatory Blood Pressure Associated With Chronic Complications in Type 2 Diabetes | 10.1038/ajh.2011.168 | 2012 |
| Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors | 10.1111/j.1478-3231.2011.02482.x | 2011 |
| High fitness is associated with a better cardiovascular risk profile in patients with type 2 diabetes mellitus | 10.1038/hr.2011.50 | 2011 |
| Uncontrolled isolated office hypertension is associated with subclinical markers of cardiovascular disease in hypertensive type 2 diabetic patients | 10.1038/hr.2010.80 | 2010 |
| Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus | 10.1111/j.1478-3231.2008.01718.x | 2009 |
| Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients | 10.1016/j.atherosclerosis.2008.12.027 | 2009 |
| Pattern of 24-Hour Ambulatory Blood Pressure Monitoring in Type 2 Diabetic Patients with Cardiovascular Dysautonomy | 10.1291/hypres.31.865 | 2008 |
| Prevalência do anticorpo anti-vírus C em doadores de sangue, grupos de risco e portadores de hepatite crônica ou cirrose não-A, não-B | 1993 | |
| Prevalência do anticorpo contra hepatite C (anti-VHC) em doadores de sangue no Rio de Janeiro, Brasil. Sua relação com ALT e anti-HBc | 1992 |
Eventos:
Nenhum evento cadastrado